With this EBITDA margin we have once again set a profitability benchmark in our industry.

165

We will continue to prune our product portfolio. We had more than 300 actives in 2000, and target about 100 actives for 2006, a further reduction of about 25% compared to the end of 2005. Ultimately we will focus on about 60 core active ingredients.

126